Brian Cicali, Ph.D., M.S.
Assistant Professor
On This Page
About Brian Cicali
Brian Cicali received his B.S. in pharmacology and toxicology from the Philadelphia College of Pharmacy, his M.S. in computational science from Stockton University, and his Ph.D. in pharmaceutical sciences from the University of Florida College of Pharmacy. He has previously held positions at GlaxoSmithKline (2013-2015), Tabula Rasa HealthCare (2016-2018), and worked as an ORISE predoctoral fellow at the U.S. F.D.A. (2019, 2020). He has received numerous awards for his research and publications including a Distinguished Research Fellowship from Stockton University (2016), the Dr. Allen J. Speigel Endowed Graduate Fellowship (2019) from University of Florida’s Department of Pharmaceutics, the Robert and Stephany Ruffolo Graduate Education and Research Fellowship (2021) from the University of Florida College of Pharmacy, the CPT:PSP award for most outstanding paper of 2019, the 2020 Most Informative Scientific Report from Simcyp academic awards, highlighted as a young leader in pharmacy by the Canadian Health Network (2022), and multiple poster awards from various conferences. Brian also serves in multiple leadership roles within national and international organizations, including the International Federation of Pharmaceuticals (FIP), American College of Clinical Pharmacology (ACCP), the International Society of Pharmacometrics (ISoP), and the American Society of Clinical Pharmacology and Therapeutics (ASCPT). His research interests focus on the use of quantitative clinical pharmacology methods to optimize drug safety and efficacy, as well as the integration of real-world evidence into clinical pharmacology analyses.
Teaching Profile
Courses Taught
-
PHA6131 – Physiologically-Based Modeling
College of Pharmacy
-
PHA6418 – Model-Informed Drug Development
College of Pharmacy
-
PHA6185 – Life Cycle of a Drug
College of Pharmacy
-
PHA6910 – Supervised Research
College of Pharmacy
-
PHA7979 – Advanced Research
College of Pharmacy
-
PHA5132 – Prin Drug Ther Indiv
College of Pharmacy
-
PHA6938 – Research Seminar
College of Pharmacy
Publications
Academic Articles
Grants
-
A Pooled Population Analysis to Evaluate the Efficacy and Safety of Lomitapide in Patients with Homozygous Familial Hypercholesterolaemia (HoFH) on Stable Lipid lowering Therapy
- Role:
- Principal Investigator
- Funding:
- AMRYT PHARMA
-
Physiologically-based Pharmacokinetic (PBPK) Modeling of Drug-drug interactions (DDI) for TEV-56268
- Role:
- Co-Investigator
- Funding:
- TEVA PHARMACEUTICALS USA
-
A Phase III, Single-arm, Open-label, International, Multi-centre Study to Evaluate the Efficacy and Safety of Lomitapide in Paediatric Patients with Homozygous Familial Hypercholesterolaemia (HoFH) on Stable Lipid-lowering Therapy
- Role:
- Co-Project Director/Principal Investigator
- Funding:
- AMRYT PHARMA
-
Characterizing efficacy and safety of hormonal contraceptives by combining pharmacometrics and RWE
Active
- Role:
- Co-Investigator
- Funding:
- BILL & MELINDA GATES FOUNDATION
-
Application of physiologically-based pharmacokinetic models to inform dosing recommendations for hormonal contraceptives co-administered with other medications
- Role:
- Project Manager
- Funding:
- BILL & MELINDA GATES FOUNDATION
Contact Details
- Business:
- (407) 313-7130
- Business:
- bcicali@ufl.edu
- Business Mailing:
-
6550 SANGER RD
ORLANDO FL 32827 - Business Street:
-
6550 SANGER RD OFC 420
ORLANDO FL 32827